you can’t work it out from Abbvie financials because they group it in with aesthetics, but the report BOT made from interviewing dermatologists listed prescribing Botox for 5% of first line, 24% of second line patients. The introduction of SB didn’t really change the Botox patients, mainly topical, Qbrexza and orals.
you can’t work it out from Abbvie financials because they group...
-
- There are more pages in this discussion • 3,452 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
-0.010(2.38%) |
Mkt cap ! $742.1M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 40.5¢ | $1.283M | 3.097M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 176075 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 455644 | 12 |
View Market Depth
| Last trade - 14.04pm 05/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |